← Back
Data updated: Mar 10, 2026
XGEN PHARMS
OncologyInfectious Disease
XGEN PHARMS is a generic drug manufacturer focused on Oncology, Infectious Disease. Key products include CYCLOPHOSPHAMIDE.
1992
Since
17
Drugs
-
Trials
156
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TRANEXAMIC ACID 2026-01-26
LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
NELARABINE 2025-11-06
Labeling
DEHYDRATED ALCOHOL 2025-10-23
Type 5 - New Formulation or New Manufacturer
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-15
Labeling
FOLIC ACID 2025-08-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 75%
3 drugs
Infectious Disease 25%
1 drugs
Pipeline Strength Pro
Loading...
Active (8)
Discontinued (9)
Company Info
- First Approval
- 1992-04-29
- Latest
- 2025-06-23
- Applications
- 18